Preoperative chemoradiotherapy (modified Eilber protocol) provides maximum local control and minimal morbidity in patients with soft tissue sarcoma

Annals of Surgical Oncology

Volumn 12, Issue 8, 2005, Pages 646-653

  Mack, Lloyd A ^a   Crowe, Phil J ^b   Jia, Lin Yang ^b   Schachar, Norman S ^a   Morris, Don G ^a   Kurien, Elizabeth C ^a   Temple, Claire L F ^a   Lindsay, Robert L ^a   Magi, Enzio ^a   DeHaas, William G ^a   Temple, Walley J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Combined modality therapy; Limb sparing surgery; Local control; Soft tissue sarcoma

Indexed keywords

ANTIBIOTIC AGENT; DOXORUBICIN; HEPARIN;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; AGED; AMPUTATION; ARTERY THROMBOSIS; ARTICLE; CANCER CONTROL; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CORRELATION ANALYSIS; FASCIA; HAZARD; HUMAN; LIMB SALVAGE; MAJOR CLINICAL STUDY; MORBIDITY; MULTIVARIATE ANALYSIS; PREOPERATIVE RADIOTHERAPY; REGRESSION ANALYSIS; REOPERATION; RISK FACTOR; SEROMA; SIDE EFFECT; SOFT TISSUE SARCOMA; STATISTICAL ANALYSIS; SURVIVAL RATE; THROMBECTOMY; WOUND; WOUND DEHISCENCE; WOUND INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; DOXORUBICIN; FEMALE; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; LEIOMYOSARCOMA; LIPOSARCOMA; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SARCOMA;

EID: 23744500827     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2005.03.064     Document Type: Article

References (31)

1. Eilber FR, Mirra JJ, Grant TT, Weisenburger T, Morton DL. Is amputation necessary for sarcomas? Ann Surg 1980;192:431-8.
2. Rosenberg SA, Tepper J, Glatstein E, et al. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 1982;196:305-15.
3. Pisters PWT, Leung DHY, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996;14:1679-89.
4. Coindre J, Terrier P, Bui NB, et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma: a study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol 1996;14:869-77.
5. Trovik CS, Bauer HCR, Berlin O, et al. Local recurrence of deep-seated, high-grade, soft tissue sarcoma: 459 patients from the Scandinavian Sarcoma Group Register. Acta Ortop Scand 2001;72:160-6.
6. Fabrizio PL, Stafford SL, Pritchard DJ. Extremity soft-tissue sarcomas selectively treated with surgery alone. Int J Radiat Oncol Biol Phys 2000;48:227-32.
7. Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998;16:197-203.
8. Zagars GK, Ballo MT, Pisters PWT, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer 2003;97:2530-43.
9. Temple WJ, Temple CLF, Arthur KA, Schachar NS, Paterson AHG, Crabtree TS. Prospective cohort study of neoadjuvant treatment in conservative surgery of soft tissue sarcomas. Ann Surg Oncol 1997;4:586-90.
10. Coindre J, Bui NB, Bonichon F, De Mascarel I, Trojani M. Histopathologic grading in spindle cell soft tissue sarcomas. Cancer 1988;61:2305-9.
11. Brennan MF. Staging of soft tissue sarcomas. Ann Surg Oncol 1999;6:8-9.
12. Kaplan EL, Meier P. len Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
13. Cox DR. Regression models and life-tables. J R Stat Soc B 1972;34:187-220.
14. Pollack A, Zagars GK, Goswitz MS, Pollock RE, Feig BW, Pisters PWT. Preoperative vs. postoperative radiotherapy in the treatment of primary soft tissue sarcoma. Int J Radiat Oncol Biol Phys 1998;42:563-72.
15. Suit HD, Mankin HJ, Wood WC, Proppe KH.. Preoperative, intraoperative, and postoperative radiation in the treatment of primary soft tissue sarcoma. Cancer 1985;55:2659-67.
16. O'Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 2002;359:2235-41.
17. Eilber FC, Rosen G, Nelson SD, et al. High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality. Ann Surg 2003;237:218-26.
18. Eilber FC, Rosen G, Eckardt J, et al. Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol 2001;19: 3203-9.
19. Eilber F, Eckardt J, Rosen G, Forscher C, Fu Y. Preoperative therapy for soft tissue sarcoma. Hematol Oncol Clin North Am 1995;9:817-23.
20. Mollabashy A, Virkus WW, Zlotecki RA, Berry BH, Scarborough MT. Radiation therapy for low-grade soft tissue sarcoma. Clin Orthop Res 2002;397:190-5.
21. Baldini EH, Goldberg J, Jenner C, et al. Long-term outcomes after function-sparing surgery without radiotherapy for soft tissue sarcoma of the extremities and trunk. J Clin Oncol 1999;17:3252-9.
22. Rydholm A, Gustafson P, Rooser B, et al. Limb-sparing surgery without radiotherapy based on anatomic location of soft tissue sarcoma. J Clin Oncol 1991;9:1757-65.
23. Popov P, Tukiainen E, Asko-Seljaavaara S, et al. Soft tissue sarcomas of the lower extremity: surgical treatment and outcome. Eur J Surg Oncol 2000;26:679-85.
24. Nielsen OS, Cummings B, O'Sullivan B, Catton C, Bell RS, Fornasier VI. Preoperative and postoperative irradiation of soft tissue sarcomas: effect of radiation field size. Int J Radiat Oncol Biol Phys 1991;21:1595-9.
25. Eilber FC, Eckardt JJ, Rosen G, Nelson SD, Selch M, Eilber FR. Large, deep, high-grade extremity sarcomas: treating tumors of the flexor fossae. Surg Oncol 1999;8:211-4.
26. Davis AM, O'Sullivan B, Bell RS, et al. Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol 2002;20: 4472-7.
27. Pisters PWT. Chemoradiation treatment strategies for localized sarcoma: conventional and investigation approaches. Semin Surg Oncol 1999;17:66-71.
28. Eilber FR, Giuliano AE, Huth JF, Weisenburger TH, Eckardt J. Intravenous (IV) vs. intraarterial (IA) Adriamycin, 2800r radiation and surgical excision for extremity soft tissue sarcomas: a randomized prospective trial. Proc Am Soc Clin Oncol 1990;9:309(abstract).
29. Pisters PWT, Harrison LB, Leung DHY, Woodruff JM, Casper ES, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 1996;14:859-68.
30. Harrison LB, Franzese F, Gaynor JJ, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in the management of completely resected soft tissue sarcomas of the extremity and superficial trunk. Int J Radiat Oncol Biol Phys 1993;27: 259-65.
31. Mack LA, Temple WJ, DeHaas WG, Schachar NS, Morris DG, Kurien E. Groin soft tissue tumors - a challenge for local control and reconstruction: a prospective cohort analysis. J Surg Oncol 2004;86:147-51.